The retrial of the lawsuit filed by Kamie Kendall was supposed to have begun in August but has reportedly been delayed. There is no word on what caused the delay or whether the delay is a sign that the defendant and Kendall are trying to settle the lawsuit. Kendall was previously awarded more than $10 million in her lawsuit against the maker of Accutane, but that award was overturned, with a judge finding that the defendant, Hoffman LaRoche, was improperly prevented from bringing important evidence before the court. The judge then sent the lawsuit back to court for a retrial.
According to some reports, there are thousands of lawsuits pending against the maker of Accutane, alleging the medication caused inflammatory bowel disease. Patients further allege they were not adequately warned about the risk of inflammatory bowel disease by Hoffman LaRoche. In some cases, the plaintiffs say they were teenagers when they started using Accutane to treat their acne—and they developed inflammatory bowel disease at a young age.
READ MORE ACCUTANE IBD LEGAL NEWS
In addition to reports of inflammatory bowel disease, Accutane has been linked to an increased risk of birth defects when pregnant women have taken the drug, and an increased risk of depression and suicide. Accutane carries a black box warning alerting patients to the risk of depression and suicide.
The maker of Accutane has lost multiple lawsuits, in which plaintiffs were awarded up to $25 million in damages for their claims.